Skip to main content
SpringerLink
Log in

HIV and the Intestine

  • Chapter
  • First Online:
Textbook of Pediatric Gastroenterology, Hepatology and Nutrition

  • 3466 Accesses

Abstract

The epidemiology of human immunodeficiency virus (HIV) infection in children is characterized by a double scenario. In countries where highly active antiretroviral therapy (HAART) is available, the pattern of HIV infection is evolving into a chronic disease, whose control strictly depends on patients’ adherence to treatment. In developing countries, with no or limited access to HAART, acquired immune deficiency syndrome (AIDS) is rapidly expanding and is loaded with a high fatality ratio, due to the combined effects of malnutrition and opportunistic infections. The digestive tract is a target of the disease in both settings. Opportunistic infections are the most common cause of gastrointestinal disease in HIV patients. However, although opportunistic causes of diarrhea have fallen dramatically in the era of HAART, overall the number of patients experiencing diarrhea has changed very little. Severe diarrhea associated with villous atrophy and crypt hypertrophy with no pathogen is found despite extensive investigation is defined as HIV enteropathy. The intestinal mucosa is a target for HIV and a site of significant HIV replication and cluster of differentiation (CD)4 T cell destruction, based upon the route of exposure and other aspects of mucosal immunology. Intestinal dysfunction is a specific HIV-related syndrome in children. Its pathophysiology is complex and involves multiple abnormalities. Although the mechanisms responsible for these abnormalities remain not completely known, several explanations have been put forward, from a virotoxic effect of HIV itself on enterocytes to an abnormal differentiation of enterocytes induced by HIV, to local activation of the gastrointestinal immune system. Intestinal infections with opportunistic agents and the complex interplay between intestinal malabsorption, immune impairment and infections are still responsible for the high incidence of intestinal dysfunction in children with HIV.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Giannattasio A, Barbarino A, Lo Vecchio A, Bruzzese E, Mango C, Guarino A. Effects of antiretroviral drug recall on perception of therapy benefits and on adherence to antiretroviral treatment in HIV-infected children. Curr HIV Res. 2009;7(5):468–72.

    Article  CAS  PubMed  Google Scholar 

  2. Giannattasio A, Albano F, Giacomet V, Guarino A. The changing pattern of adherence to antiretroviral therapy assessed at two time points, 12 months apart, in a cohort of HIV-infected children. Expert Opin Pharmacother. 2009;10(17):2773–8. doi:10.1517/14656560903376178.

    Article  CAS  PubMed  Google Scholar 

  3. Guarino A, Bruzzese E, De Marco G, Buccigrossi V. Management of gastrointestinal disorders in children with HIV infection. Paediatr Drugs. 2004;6(6):347–62.

    Article  PubMed  Google Scholar 

  4. Li Q, Duan L, Estes JD, Ma ZM, Rourke T, Wang Y, Reilly C, Carlis J, Miller CJ, Haase AT. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature. 2005;434(7037):1148–52.

    CAS  PubMed  Google Scholar 

  5. Cello JP, Day LW. Idiopathic AIDS enteropathy and treatment of gastrointestinal opportunistic pathogens. Gastroenterology. 2009;136(6):1952–65. doi:10.1053/j.gastro.2008.12.073 (Epub 2009 May 7).

    Article  CAS  PubMed  Google Scholar 

  6. Mönkemüller KE, Call SA, Lazenby AJ, Wilcox CM. Declining prevalence of opportunistic gastrointestinal disease in the era of combination antiretroviral therapy. Am J Gastroenterol. 2000;95(2):457–62.

    Article  PubMed  Google Scholar 

  7. Mönkemüller KE, Lazenby AJ, Lee DH, Loudon R, Wilcox CM. Occurrence of gastrointestinal opportunistic disorders in AIDS despite the use of highly active antiretroviral therapy. Dig Dis Sci. 2005;50(2):230–4.

    Article  PubMed  Google Scholar 

  8. Wilcox CM, Saag MS. Gastrointestinal complications of HIV infection: changing priorities in the HAART era. Gut. 2008;57(6):861–70. doi:10.1136/gut.2006.103432 (Epub 2008 Jan 18).

    Article  CAS  PubMed  Google Scholar 

  9. Wilcox CM, Straub RF, Schwartz DA. Prospective evaluation of biopsy number for the diagnosis of viral esophagitis in patients with HIV infection and esophageal ulcer. Gastrointest Endosc. 1996;44(5):587–93.

    Article  CAS  PubMed  Google Scholar 

  10. Anastasi JK, Capili B. HIV and diarrhea in the era of HAART: 1998 New York state hospitalizations. Am J Infect Control. 2000;28(3):262–6.

    Article  CAS  PubMed  Google Scholar 

  11. Guest JL, Ruffin C, Tschampa JM, DeSilva KE, Rimland D. Differences in rates of diarrhea in patients with human immunodeficiency virus receiving lopinavir-ritonavir or nelfinavir. Pharmacotherapy. 2004;24(6):727–35.

    Article  CAS  PubMed  Google Scholar 

  12. Price JC, Thio CL. Liver disease in the HIV-infected individual. Clin Gastroenterol Hepatol. 2010;8(12):1002–12. doi:10.1016/j.cgh.2010.08.024 (Epub 2010 Sept 17)

    Article  PubMed Central  PubMed  Google Scholar 

  13. Carroccio A, Fontana M, Spagnuolo MI, Zuin G, Montalto G, Canani RB, Verghi F, Di Martino D, Bastoni K, Buffardi F, Guarino A. Pancreatic dysfunction and its association with fat malabsorption in HIV infected children. Gut. 1998;43(4):558–63.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  14. Kotler DP, Gaetz HP, Lange M, Klein EB, Holt PR. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med. 1984;101(4):421–8.

    Article  CAS  PubMed  Google Scholar 

  15. Batman PA, Miller AR, Forster SM, Harris JR, Pinching AJ, Griffin GE. Jejunal enteropathy associated with human immunodeficiency virus infection: quantitative histology. J Clin Pathol. 1989;42(3):275–81.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  16. Sankaran S, George MD, Reay E, Guadalupe M, Flamm J, Prindiville T, Dandekar S. Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol. 2008;82(1):538–45 (Epub 2007 Oct 24).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. George MD, Reay E, Sankaran S, Dandekar S. Early antiretroviral therapy for simian immunodeficiency virus infection leads to mucosal CD4+ T-cell restoration and enhanced gene expression regulating mucosal repair and regeneration. J Virol. 2005;79(5):2709–19.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Costiniuk CT, Angel JB. Human immunodeficiency virus and the gastrointestinal immune system: does highly active antiretroviral therapy restore gut immunity? Mucosal Immunol. 2012;5(6):596–604. doi:10.1038/mi.2012.82 (Epub 2012 Aug 29).

    Article  CAS  PubMed  Google Scholar 

  19. Brenchley JM, Douek DC. HIV infection and the gastrointestinal immune system. Mucosal Immunol. 2008;1(1):23–30. doi:10.1038/mi.2007.1.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Knox TA, Spiegelman D, Skinner SC, Gorbach S. Diarrhea and abnormalities of gastrointestinal function in a cohort of men and women with HIV infection. Am J Gastroenterol. 2000;95(12):3482–9.

    Article  CAS  PubMed  Google Scholar 

  21. Canani RB, De Marco G, Passariello A, Buccigrossi V, Ruotolo S, Bracale I, Porcaro F, Bifulco G, Guarino A. Inhibitory effect of HIV-1 Tat protein on the sodium-D-glucose symporter of human intestinal epithelial cells. AIDS. 2006;20(1):5–10.

    Article  CAS  PubMed  Google Scholar 

  22. Maresca M, Mahfoud R, Garmy N, Kotler DP, Fantini J, Clayton F. The virotoxin model of HIV-1 enteropathy: involvement of GPR15/Bob and galactosylceramide in the cytopathic effects induced by HIV-1 gp120 in the HT-29-D4 intestinal cell line. J Biomed Sci. 2003;10(1):156–66.

    Article  CAS  PubMed  Google Scholar 

  23. Heise C, Dandekar S, Kumar P, Duplantier R, Donovan RM, Halsted CH. Human immunodeficiency virus infection of enterocytes and mononuclear cells in human jejunal mucosa. Gastroenterology. 1991;100(6):1521–7.

    CAS  PubMed  Google Scholar 

  24. Clayton F, Kapetanovic S, Kotler DP. Enteric microtubule depolymerization in HIV infection: a possible cause of HIV-associated enteropathy. AIDS. 2001;15(1):123–4.

    Article  CAS  PubMed  Google Scholar 

  25. McGowan I, Elliott J, Fuerst M, Taing P, Boscardin J, Poles M, Anton P. Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation. J Acquir Immune Defic Syndr. 2004;37(2):1228–36.

    Article  CAS  PubMed  Google Scholar 

  26. Cheroutre H, Madakamutil L. Acquired and natural memory T cells join forces at the mucosal front line. Nat Rev Immunol. 2004;4(4):290–300.

    Article  CAS  PubMed  Google Scholar 

  27. Kotler DP. HIV infection and the gastrointestinal tract. AIDS. 2005;19(2):107–17.

    Article  PubMed  Google Scholar 

  28. Dandekar S. Pathogenesis of HIV in the gastrointestinal tract. Curr HIV/AIDS Rep. 2007;4:10–15.

    Article  PubMed  Google Scholar 

  29. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, van Steenwijk RP, Lange JM, Schattenkerk JK, Miedema F, Tersmette M. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J Virol. 1992;66(3):1354–60.

    PubMed Central  CAS  PubMed  Google Scholar 

  30. Schneider T, Jahn HU, Schmidt W, Riecken EO, Zeitz M, Ullrich R. Loss of CD4 T lymphocytes in patients infected with human immunodeficiency virus type 1 is more pronounced in the duodenal mucosa than in the peripheral blood. Berlin Diarrhea/Wasting Syndrome Study Group. Gut. 1995;37(4):524–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Smit-McBride Z, Mattapallil JJ, McChesney M, Ferrick D, Dandekar S. Gastrointestinal T lymphocytes retain high potential for cytokine responses but have severe CD4(+) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J Virol. 1998;72(8):6646–56.

    PubMed Central  CAS  PubMed  Google Scholar 

  32. Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J Exp Med. 2004;200(6):761–70 (Epub 2004 Sept 13).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  33. Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, Douek DC. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004;200(6):749–59 (Epub 2004 Sept 13).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Mehandru S, Poles MA, Tenner-Racz K, Manuelli V, Jean-Pierre P, Lopez P, Shet A, Low A, Mohri H, Boden D, Racz P, Markowitz M. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J Virol. 2007;81(2):599–612 (Epub 2006 Oct 25).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci U S A. 1989;86(15):5974–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  36. Kotler DP, Shimada T, Snow G, Winson G, Chen W, Zhao M, Inada Y, Clayton F. Effect of combination antiretroviral therapy upon rectal mucosal HIV RNA burden and mononuclear cell apoptosis. AIDS. 1998;12(6):597–604.

    Article  CAS  PubMed  Google Scholar 

  37. Zocchi MR, Rubartelli A, Morgavi P, Poggi A. HIV-1 Tat inhibits human natural killer cell function by blocking L-type calcium channels. J Immunol. 1998;161(6):2938–43.

    CAS  PubMed  Google Scholar 

  38. Haughey NJ, Holden CP, Nath A, Geiger JD. Involvement of inositol 1,4,5-trisphosphate-regulated stores of intracellular calcium in calcium dysregulation and neuron cell death caused by HIV-1 protein tat. J Neurochem. 1999;73(4):1363–74.

    Article  CAS  PubMed  Google Scholar 

  39. Canani RB, Cirillo P, Mallardo G, Buccigrossi V, Secondo A, Annunziato L, Bruzzese E, Albano F, Selvaggi F, Guarino A. Effects of HIV-1 Tat protein on ion secretion and on cell proliferation in human intestinal epithelial cells. Gastroenterology. 2003;124(2):368–76.

    Article  CAS  PubMed  Google Scholar 

  40. Agrawal L, Louboutin JP, Strayer DS. Preventing HIV-1 Tat-induced neuronal apoptosis using antioxidant enzymes: mechanistic and therapeutic implications. Virology. 2007;363:462–72.

    Article  CAS  PubMed  Google Scholar 

  41. Kline ER, Sutliff RL. The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction. J Investig Med. 2008;6:752–69.

    Article  Google Scholar 

  42. Stehbens WE. Oxidative stress in viral hepatitis and AIDS. Exp Mol Pathol. 2004;77:121–32.

    Article  CAS  PubMed  Google Scholar 

  43. Banerjee A, Zhang X, Manda KR, Banks WA, Ercal N. HIV proteins (gp120 and Tat) and methamphetamine in oxidative stress-induced damage in the brain: potential role of the thiol antioxidant N-acetylcysteine amide. Free Radic Biol Med. 2010;48:1388–98.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  44. Buccigrossi V, Laudiero G, Nicastro E, Miele E, Esposito F, Guarino A. The HIV-1 transactivator factor (Tat) induces enterocyte apoptosis through a redox-mediated mechanism. PLoS One. 2011;6(12):e29436. doi:10.1371/journal.pone.0029436 (Epub 2011 Dec 27).

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Mehandru S, Poles MA, Tenner-Racz K, Jean-Pierre P, Manuelli V, Lopez P, Shet A, Low A, Mohri H, Boden D, Racz P, Markowitz M. Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection. PLoS Med. 2006;3(12):e484.

    Article  PubMed Central  PubMed  Google Scholar 

  46. Guadalupe M, Sankaran S, George MD, Reay E, Verhoeven D, Shacklett BL, Flamm J, Wegelin J, Prindiville T, Dandekar S. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol. 2006;80(16):8236–47.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. Shacklett BL. Immune responses to HIV and SIV in mucosal tissues: ‘location, location, location’. Curr Opin HIV AIDS. 2010;5(2):128–34. doi:10.1097/COH.0b013e328335c178.

    Article  PubMed Central  PubMed  Google Scholar 

  48. Estes J, Baker JV, Brenchley JM, Khoruts A, Barthold JL, Bantle A, Reilly CS, Beilman GJ, George ME, Douek DC, Haase AT, Schacker TW. Collagen deposition limits immune reconstitution in the gut. J Infect Dis. 2008;198(4):456–64. doi:10.1086/590112.

    Article  PubMed Central  PubMed  Google Scholar 

  49. Chun TW, Nickle DC, Justement JS, Meyers JH, Roby G, Hallahan CW, Kottilil S, Moir S, Mican JM, Mullins JI, Ward DJ, Kovacs JA, Mannon PJ, Fauci AS. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis. 2008;197(5):714–20. doi:10.1086/527324.

    Article  CAS  PubMed  Google Scholar 

  50. Holmes CB, Wood R, Badri M, et al. CD4 decline and incidence of opportunistic infections in Cape Town, South Africa: implications for prophylaxis and treatment. J Acquir Immune Defic Syndr. 2006;42:464–9.

    Article  PubMed  Google Scholar 

  51. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA. 2001;286:2568–77.

    Article  CAS  PubMed  Google Scholar 

  52. Kaplan JE, Hanson DL, Jones JL, et al. Viral load as an independent risk factor for opportunistic infections in HIV infectd adults and adolescents. AIDS. 2001;15:722–6.

    Article  Google Scholar 

  53. Kotler DP, Reka S, Orenstein JM, Fox CF. Chronic idiopathic esophageal ulceration in the acquired immunodeficiency syndrome: characterization and treatment with corticosteroids. J Clin Gastroenterol. 1992;15:284–90.

    Article  CAS  PubMed  Google Scholar 

  54. Huppmann AR, Orenstein JM. Opportunistic disorders of the gastrointestinal tract in the age of highly active antiretrovirual therapy. Hum Pathol. 2010;41:1777–87.

    Article  PubMed  Google Scholar 

  55. Wilcox CM, Alexander LN, Clarck WS, et al. Fluconazole compared with encoscopy for human immunodeficiency-virus infected patients with esophageal symptoms. Gastroenterology. 1996;110:1803–9.

    Article  CAS  PubMed  Google Scholar 

  56. Weeneck-Silva AL, Prado IB. Dyspepsia in HIV-infected patients under highly active antiretroviral therapy. J Gastroenterol Hepatol. 2007;11:1712–16.

    Article  Google Scholar 

  57. Mach T, Skwara P, Biesiada G, et al. Morphological changes of the upper gastrointestinal tract mucosa and Helicobacter pylori infection in HIV-positive patients with severe immunodeficiency and symptoms of dyspepsia. Med Sci Monit. 2007;13:14–9.

    Google Scholar 

  58. Tomilo DL, Smith PF, Ogundeele AB, et al. Inhibition of atazanavir oral absorption by lansoprazole gastric acid suppression in healthy volunteers. Pharmacotherapy. 2006;26:341.

    Article  CAS  PubMed  Google Scholar 

  59. Weerneck-Silva AL, Prado IB. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of highly active antiretroviral therapy. J Gastroenterol Hepatol. 2009;24:135–9.

    Article  Google Scholar 

  60. Keush GT, Thea DM, Kamenga M, et al. Persistent diarrhea associated with AIDS. Acta Paediatr Suppl. 1992;382:45–8.

    Article  Google Scholar 

  61. Groome MJ, Madhi SA. Five-yearcohortstudy on the burden of hospitalisation for acute diarrhoealdisease in African HIV-infected and HIV-uninfectedchildren: potential benefits of rotavirus vaccine. Vaccine. 2012;30 Suppl 1:A173–8.

    Article  PubMed  Google Scholar 

  62. Connoly GM, Shanson D, Hawkins DA, et al. Non-cryptosporidiual diarrhea in human immunodeficiency virus infected patinets. Gut. 1989;30:195–200.

    Article  Google Scholar 

  63. Elfstrand L, Floren CH. Management of chronic diarrhea in HIV-infected patinets: current treatment options, challenges and future directions. HIV/AIDS Palliat Care. 2010;2:219–24.

    Article  Google Scholar 

  64. Sanchez TH, Brooks JT, Sullivan PS, et al. Bacterial diarrhea in persons with HIV infection, United States, 1992–2002. CID. 2005;41:1621–7.

    Article  Google Scholar 

  65. Braeckman T, Van Herck K, et al. Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study. Br Med J. 2012;345:e4752.

    Article  Google Scholar 

  66. Armah GE, Breiman RF, Tapia MD, et al. Immunogenicity of the pentavalent rotavirus vaccine in African infants. Vaccine. 2012;30 Suppl 1:A86–93.

    Article  CAS  PubMed  Google Scholar 

  67. Mphahlele MJ, Mda S. Immunising the HIV-infected child: a view from sub-Saharan Africa. Vaccine. 2012;30 Suppl 3:C61–5.

    Article  PubMed  Google Scholar 

  68. Payne DC, Vinje J, et al. Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med. 2013;368:1121–30.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  69. Wingfield T, Gallimore CI, Xerry J, et al. Chronic norovirus infection in an HIV- positive patient with persistent diarrhea: a novel cause. J Clin Virol. 2010;49:219–22.

    Article  PubMed  Google Scholar 

  70. Salzberg B, Hartmann P, Hanses F, et al. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy. Infection. 2005;33:345–9.

    Article  Google Scholar 

  71. Ukarapol N, Chartapisak W, Lertprasertsuk N, et al. Cytomegalovirus-associated manifestations involving the digestive tract in children with human immunodeficiency virus infection. J Pediatr Gastroenterol Nutr. 2002;35:669–73.

    Article  CAS  PubMed  Google Scholar 

  72. Dietrich DT, Kotler DP, Brush DF, et al. Ganciclovirtrestment of cytomegalovirus colitis in AIDS: a randomized double blind placebo-controlled multicenter study. J Infect Dis. 1993;167:278–82.

    Article  Google Scholar 

  73. Feasey NA, Healey P, Gordon MA. Review article: the aetiology, investigation and management of diarrhea in the HIV-positive patient. Aliment Pharmacol Ther. 2011;34(6):587–603. doi:10.1111/j.1365-2036.2011.04781.x (Epub 2011 July 20).

    Article  CAS  PubMed  Google Scholar 

  74. Agholi M, Hatam GR, Motazedian MH. HIV/AIDS-associated opportunistic protozoal diarrhea. AIDS Res Hum Retroviruses. 2013;29:35–41.

    Article  PubMed Central  PubMed  Google Scholar 

  75. Idris NS, Dwipoerwantoro PG, Kurniawan A, Said M. Intestinal parasitic infection of immunocompromised children with diarrhea: clinical profile and therapeutic response. J Infect Dev Ctries. 2010;4:309–17.

    Article  CAS  PubMed  Google Scholar 

  76. Maikai BV, Umoh JU, Lawal IA, et al. Molecular characterizations of Cryptosporidium, Giardia, and Enterocytozoon in humans in Kaduna State, Nigeria. Exp Parasitol. 2012;131:452–6.

    Article  CAS  PubMed  Google Scholar 

  77. Zulu I, Veitch A, Sianongo S, et al. Albendazole chemotherapy for AIDS-related diarrhea in Zambia: clinical, parasitological and mucosal responses. Aliment Pharmacol Ther. 2002;16:595–601.

    Article  CAS  PubMed  Google Scholar 

  78. Mor SM, Tumwine JK, Naumova EN, et al. Microsporidiosis and malnutrition in children with persistent diarrhea, Uganda. Emerg Infect Dis. 2009;15:49–52.

    Article  PubMed Central  PubMed  Google Scholar 

  79. Barratt JLN, Harkness J, Marriott D, et al. Importance of nonenteric protozoan infections in immunocompromised people. Clin Microbiol Rev. 2010;23:795–836.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  80. Pagornrat W, Leelayoova S, Rangsin R, et al. Carriage rate of Enterocytozoon bieneusi in an orphanage in Bangkok, Thailand. J Clin Microbiol. 2009;47:3739–41.

    Article  PubMed Central  PubMed  Google Scholar 

  81. Vaishnavi C, Kaur S, Prakash S. Speciation of fecal Candida isolates in antibiotic-associated diarrhea in non-HIV patients. Jpn J Infect Dis. 2008;61:1–4.

    PubMed  Google Scholar 

  82. Berni Canani R, Ruotolo S, Buccigrossi V, et al. Zinc fights diarrhea in HIV-1-infected children: in-vitro evidence to link clinical data and pathophysiological mechanism. AIDS. 2007;21(1):108–10.

    Article  Google Scholar 

  83. Buccigrossi V, Giannattasio A, Armellino C, Lo Vecchio A, Caiazzo MA, Guarino A. The functional effects of nutrients on enterocyte proliferation and intestinal ion transport in early infancy. Early Hum Dev. 2010;86 Suppl 1:55–7. doi:10.1016/j.earlhumdev.2010.01.008 (Epub 2010 Feb 13).

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Pediatrics, Department of Translational Medical Science, University of Naples “Federico II”, Via S. Pansini 5, 80131, Naples, Italy

    Andrea Lo Vecchio, Antonietta Giannattasio & Alfredo Guarino

Authors
  1. Andrea Lo Vecchio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antonietta Giannattasio
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Alfredo Guarino
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Lo Vecchio .

Editor information

Editors and Affiliations

  1. Department of Pediatrics, University of Chicago, Chicago, Illinois, USA

    Stefano Guandalini

  2. Clinical Director Child Health King’s College Hospital, Professor and Director Pediatric Liver, GI and Nutrition Center, London, United Kingdom

    Anil Dhawan

  3. Department of Pediatrics, Hebrew University Hadassah Hospital, Jerusalem, Israel

    David Branski

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Lo Vecchio, A., Giannattasio, A., Guarino, A. (2016). HIV and the Intestine. In: Guandalini, S., Dhawan, A., Branski, D. (eds) Textbook of Pediatric Gastroenterology, Hepatology and Nutrition. Springer, Cham. https://doi.org/10.1007/978-3-319-17169-2_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-17169-2_18

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-17168-5

  • Online ISBN: 978-3-319-17169-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation